3i Group (OTCMKTS:TGOPY) Shares Gap Down – Time to Sell?

by · The Markets Daily

3i Group plc – Unsponsored ADR (OTCMKTS:TGOPY – Get Free Report)’s share price gapped down before the market opened on Monday . The stock had previously closed at $11.21, but opened at $10.89. 3i Group shares last traded at $10.73, with a volume of 531,254 shares changing hands.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on TGOPY shares. Royal Bank Of Canada downgraded shares of 3i Group to an “underperform” rating in a research report on Monday. UBS Group upgraded 3i Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 2nd. Kepler Capital Markets lowered shares of 3i Group from a “hold” rating to a “strong sell” rating in a research report on Friday, November 14th. Finally, Citigroup reiterated a “buy” rating on shares of 3i Group in a research note on Friday, November 14th. Three analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Get Our Latest Report on 3i Group

3i Group Stock Performance

The company has a 50 day moving average of $10.75 and a two-hundred day moving average of $15.07.

About 3i Group

(Get Free Report)

3i Group plc is a London‑based international investment manager that specializes in private equity, infrastructure and debt investments. The company deploys capital both from its own balance sheet and through managed funds on behalf of institutional investors, targeting mid‑market buyouts, growth capital and core infrastructure assets. Its private equity activity typically focuses on acquiring, developing and exiting businesses through active ownership and operational improvement, while its infrastructure arm invests in long‑life assets that generate steady cash flows.

3i manages a portfolio of companies across a range of industry sectors, including business and financial services, industrials, consumer and healthcare, and technology.

See Also